Your browser doesn't support javascript.
loading
Telomere length predicts for outcome to FCR chemotherapy in CLL.
Norris, Kevin; Hillmen, Peter; Rawstron, Andrew; Hills, Robert; Baird, Duncan M; Fegan, Christopher D; Pepper, Chris.
Afiliação
  • Norris K; Division of Cancer & Genetics, Cardiff University, School of Medicine, Heath Park, Cardiff, UK.
  • Hillmen P; Section of Experimental Haematology, Leeds Institute of Cancer and Pathology (LICAP), University of Leeds, Leeds, UK.
  • Rawstron A; Section of Experimental Haematology, Leeds Institute of Cancer and Pathology (LICAP), University of Leeds, Leeds, UK.
  • Hills R; Nuffield Department of Population Health, University of Oxford, Richard Doll Building, Old Road Campus, Roosevelt Drive, Oxford, OX3 7LF, USA.
  • Baird DM; Division of Cancer & Genetics, Cardiff University, School of Medicine, Heath Park, Cardiff, UK.
  • Fegan CD; Division of Cancer & Genetics, Cardiff University, School of Medicine, Heath Park, Cardiff, UK.
  • Pepper C; Division of Cancer & Genetics, Cardiff University, School of Medicine, Heath Park, Cardiff, UK. c.pepper@bsms.ac.uk.
Leukemia ; 33(8): 1953-1963, 2019 08.
Article em En | MEDLINE | ID: mdl-30700843
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica / Telômero Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica / Telômero Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article